Chief Executive Officer - Louvain

For a start-up in cutting-edge vaccine development, we are looking for a CEO to lead commercialisation. The organisation existed before Covid-19, but got additional funding to expand its unique formula. The technology is considered a second-generation vaccine and promises permanent resistance to not only Covid-19 but in the end, also become a broader platform for a multitude of diseases. As the organisation is in a transformational phase, it is unclear if whether the organisation will take the shape of a joint venture or become a fully independent organisation. The goal is to have you join during this transformational phase and co-decide as well as advise about the what, when, and how. Depending on which shape is chosen, it is up to you to lead and grow the team, and not only focus on the win but also involve the application possibilities in third world countries. You will work with very passionate colleagues, that are highly experienced in virology, so you do not need to be an expert yourself, but you must be able to understand the science.